GALECTIN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Exce...
August 22 2014 - 10:00PM
Business Wire
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former
Attorney General of Louisiana, Charles C. Foti, Jr., remind
investors that they have until September 29, 2014 to file
lead plaintiff applications in a securities class action lawsuit
against Galectin Therapeutics Inc. (Nasdaq: GALT), if they
purchased the Company’s securities during the period between
January 6, 2014 and July 28, 2014, inclusive (the “Class Period”).
This action is pending in the United States District Court for the
District of Nevada.
What You May Do
If you purchased shares of Galectin and would like to discuss
your legal rights and how this case might affect you and your right
to recover for your economic loss, you may, without obligation or
cost to you, call toll-free at 1-877-515-1850 or email KSF Managing
Partner Lewis Kahn (lewis.kahn@ksfcounsel.com). If you wish to serve
as a lead plaintiff in this class action, you must petition the
Court by September 29, 2014.
About the Lawsuit
Galectin and certain of its executives are charged with issuing
a series of materially false and misleading statements during the
Class Period, violating federal securities laws.
On July 24, 2014, Emerging Growth Corp. issued a press release
touting Galectin and stating that Galectin was "nipping at [the]
heels" of its competitors. Then, on July 28, 2014, an article on
SeekingAlpha.com claimed that Galectin had "strong ties to stock
promoters" engaging in a misleading campaign aimed at boosting its
stock price, and an article on TheStreet.com revealed that Emerging
Growth was the investor relations and marketing company Galectin
was paying for misleading promotional campaigns to entice investors
to buy its stock.
On this news, the value of Galectin’s stock plummeted by
61%.
About Kahn Swick & Foti, LLC
To learn more about KSF, whose partners include the Former
Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers
with significant experience litigating complex securities class
actions nationwide on behalf of both institutional and individual
shareholders, you may visit www.ksfcounsel.com.
Kahn Swick & Foti, LLCLewis Kahn, 1-877-515-1850Managing
Partnerlewis.kahn@ksfcounsel.com
Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Apr 2023 to Apr 2024